Login to Your Account

ARYx Signs P&G To $435M Agreement For Lead GI Drug

By Karen Pihl-Carey

Thursday, July 13, 2006
Privately held ARYx Therapeutics Inc. signed its first major partnership since its founding in 1998, granting to Procter & Gamble Pharmaceuticals Inc. worldwide development and commercialization rights to ATI-7505 in gastrointestinal disorders. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription